The physics of a foam that doesn’t drip
Why fast-breaking foams outperform creams and solutions for scalp penetration — surface tension, evaporation kinetics, and a supersaturated film.
Delivering a drug to the scalp is a surprisingly hostile engineering problem. A liquid solution runs off before it can act and drips onto the forehead and collar. A cream smears greasily through the hair and never properly reaches the follicular openings. The scalp is also densely haired, sebaceous and constantly moving. The vehicle, not the active, is where most scalp therapies succeed or fail.
What a fast-breaking foam actually does
A fast-breaking foam is a low-viscosity liquid pressurised into a bubble matrix that expands on contact with the warmth of the skin and then collapses back to a thin liquid film within thirty to sixty seconds. That brief foam phase lets the product be placed precisely and worked to the scalp between hairs without running; the collapse phase delivers a uniform, thin residue exactly where it was placed, with no occlusive greasy layer left behind.
Three parameters that decide penetration
Foam performance comes down to three physical variables. Surface tension governs how the collapsing liquid spreads and wets the scalp. Evaporation kinetics control how fast the volatile carrier leaves. And the diffusion coefficient of the active in the drying residue determines how readily it moves into the stratum corneum. Tune these together and something useful happens: as the carrier evaporates, the minoxidil left behind becomes supersaturated — present above its normal solubility — sharply raising the driving force pushing it across the corneum.
Doing it without propylene glycol
Older minoxidil solutions leaned on propylene glycol as a solubiliser and penetration enhancer. It works, but it is a common cause of scalp irritation and contact dermatitis — and an itchy, flaking scalp is a fast route to a patient quitting. A well-designed foam achieves supersaturation-driven delivery without propylene glycol, trading a problematic excipient for smarter physics.
The unglamorous conclusion
All of this serves one clinical fact: in androgenetic alopecia, adherence is half the battle. A foam that dries in a minute, leaves no residue and does not sting is a foam people keep using — and in hair loss, the therapy you continue for years is the one that works. Vehicle design is where that battle is quietly won.
A quick-drying, propylene-glycol-free foam engineered to deliver minoxidil to the follicle and stay there — a vehicle designed for the one metric that decides hair-loss outcomes: whether the patient keeps applying it.
View in the formulary →